首页|期刊导航|骨研究（英文版）|uPAR antibody (huATN-658) and Zometa reduce breast cancer growth and skeletal lesions

uPAR antibody (huATN-658) and Zometa reduce breast cancer growth and skeletal lesions

Niaz Mahmood Ani Arakelian Haseeb Ahmed Khan Imrana Tanvir Andrew P.Mazar Shafaat A.Rabbani

骨研究（英文版）2020，Vol.8Issue(2)：197-208,12.

uPAR antibody (huATN-658) and Zometa reduce breast cancer growth and skeletal lesions

Niaz Mahmood ¹Ani Arakelian ¹Haseeb Ahmed Khan ²Imrana Tanvir ²Andrew P.Mazar ³Shafaat A.Rabbani¹

作者信息

1. Department of Medicine,McGill University,Montréal,QC H4A3J1,Canada
2. Fatima Memorial Hospital System,Lahore,Pakistan
3. Monopar Therapeutics,Wilmette,IL 60091,USA
折叠

摘要

引用本文复制引用

Niaz Mahmood,Ani Arakelian,Haseeb Ahmed Khan,Imrana Tanvir,Andrew P.Mazar,Shafaat A.Rabbani..uPAR antibody (huATN-658) and Zometa reduce breast cancer growth and skeletal lesions[J].骨研究（英文版）,2020,8(2):197-208,12.

基金项目

This work was supported by grants from the Canadian Institutes for Health Research (PJT-156225) to SAR. （PJT-156225）

骨研究（英文版）

OACSCDSCI

ISSN：2095-4700

访问量0

下载量0

段落导航